Categories Earnings, U.S. Markets News
Calendar: Earnings of Bank of America, IBM, United Airlines, PepsiCo on queue
Bank of America, IBM, United Airlines, PepsiCo and more earnings are scheduled for the week between April 15 and 19. Check out what to expect from the major earnings reports this week.
Citigroup (NYSE: C) will announce first-quarter earnings on Monday before the bell. Analysts expect earnings to climb 7.10% to $1.80 per share while revenues will decline by 1.30% to $18.63 billion. The bottom line results will be benefited by the bank’s cost-cutting initiatives while the top line will be hurt by the negative impact of the fixed income securities business.
Investment banking giant Goldman Sachs (NYSE: GS) will report first-quarter results on Monday. Analysts predict earnings of $4.89 per share on revenue of $9.04 billion. The results are anticipated to be hurt by continued weakness in the trading and investment banking business. The economic volatility and the government shutdown have pressurized the trading volume and overall activity that remained subdued in the initial months of the year.
Bank of America Corporation (NYSE: BAC) is set to post first-quarter results on Tuesday before the bell. Analysts expect earnings to increase by 4.80% to $0.65 per share helped by higher interest rates and tax reform benefits. Revenue is anticipated to rise 0.10% to $23.3 billion as benefits from higher interest rates as well as loan and deposit growth could drive net interest income higher.
Johnson & Johnson (NYSE: JNJ) will post Q1 results on Tuesday. Analysts project the company to report earnings of $2.04 per share on revenue of $19.61 billion. The results will be hurt by the weakness in the medical devices segment and a slowdown in sales. Despite this, the pharmaceutical unit will continue to be the main revenue generator, led by Imbruvica, Darzalex Stelara, and Zytiga. The management remained bullish on the stable demand for consumer health products and medical devices.
Netflix (NASDAQ: NFLX) will announce Q1 earnings on Tuesday after the bell. Earnings are expected to fall 10.90% to $0.57 per share while revenue is likely to jump by 21.60% to $4.5 billion. The results will be hurt by a decline in subscribers in the streaming segment as the price hike pressurized the domestic subscriber growth. The rising competition from Apple (NASDAQ: AAPL), Walt Disney (NYSE: DIS), Amazon (NASDAQ: AMZN) and Facebook (NASDAQ: FB) could be hurting the company’s results for the first quarter.
International Business Machines (NYSE: IBM) is set to post first-quarter results on Tuesday. Analysts project earnings to fall 9.40% to $2.22 per share and revenue to decline by 2.90% to $18.51 billion. The company has been aggressively shifting its focus to new technology in response to the persistent downtrend in topline performance, primarily due to the faltering demand for PCs and mainframe products. The spending of $34 billion for buying Red Hat (NYSE: RHT) could be hurting the company’s results.
Also read: Abiomed stock falls to yearly low
United Airlines parent United Continental Holdings (NASDAQ: UAL) will report Q1 earnings on Tuesday. Analysts see a profit of $0.94 per share on revenue of $9.6 billion. The bottom line is likely to be hurt by higher fuel expenses. However, the results will be benefited by the successful implementation of its strategic plan and to record-setting its operational performance. The airline sector has been hurt by the prolonged shutdown of the government.
Morgan Stanley (NYSE: MS) could post Q1 results on Wednesday before the bell. Earnings are anticipated to fall 20% to $1.16 per share and revenue is likely to decline 9.70% to $10 billion. The results will be hurt by the discrete tax provision related to the resolution of multi-jurisdiction tax examinations. The economic volatility and the government shutdown have pressurized the trading volume and overall activity.
Abbott Laboratories (NYSE: ABT) will report Q1 earnings on Wednesday. Analysts see a profit of $0.61 per share on revenue of $7.47 billion. The results will be benefited by the higher sales from Medical Devices and Diagnostics businesses. The diagnostic instruments Alinity and infectious disease testing could drive Diagnostics sales higher. The cardiac mapping, ablation catheters, Structural Heart and Diabetes Care could drive sales of Medical Devices higher.
Also read: Can Aurora Cannabis outrun Canopy Growth and Tilray in marijuana race?
As PepsiCo Inc. (NASDAQ: PEP) announces Q1 results on Wednesday, analysts expect earnings of $0.92 per share on revenue of $12.7 billion. The top line results will be benefited by the growth in its Frito-Lay North America and North America Beverages segments. However, the bottom line will be impacted by incremental investments to strengthen the business. An increase in operating costs and expenses could hurt the bottom line results.
Credit card operator American Express (NYSE: AXP) will report Q1 earnings on Thursday before the bell. Analysts see a profit of $1.98 per share on revenue of $10.45 billion. The results will be benefited by an increase in cardmember spending, loan volumes and card fees. The growth is expected to be broad-based and well-balanced across geographies and business lines. The provisions for losses could rise due to loan portfolios and lending write-off rate.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.
ACN Earnings: All you need to know about Accenture’s Q2 2023 earnings results
Accenture (NYSE: ACN) reported second quarter 2023 earnings results today. Total revenues increased 5% year-over-year to $15.8 billion. Net income attributable to Accenture plc was $1.52 billion, or $2.39 per
Here’s how FedEx (FDX) plans to soften the impact of volume declines on its business
Shares of FedEx Corporation (NYSE: FDX) stayed green on Wednesday. The stock has gained 26% year-to-date. The company faced a challenging environment in the third quarter of 2023 which took
Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with the transformation the healthcare space is witnessing. Currently,